J.P. Morgan Private Wealth Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,181
| Closed | -$330K | – | 2036 |
|
|
2022
Q3 | $330K | Sell |
2,181
-5,935
| -73% | -$898K | ﹤0.01% | 1616 |
|
|
2022
Q2 | $1.18M | Sell |
8,116
-11,169
| -58% | -$1.63M | ﹤0.01% | 1048 |
|
|
2022
Q1 | $2.29M | Sell |
19,285
-7,972
| -29% | -$945K | 0.01% | 857 |
|
|
2021
Q4 | $3.76M | Buy |
27,257
+6,376
| +31% | +$879K | 0.01% | 694 |
|
|
2021
Q3 | $2.9M | Buy |
20,881
+7,318
| +54% | +$1.02M | 0.01% | 755 |
|
|
2021
Q2 | $1.32M | Buy |
13,563
+8,870
| +189% | +$861K | ﹤0.01% | 1061 |
|
|
2021
Q1 | $321K | Buy |
+4,693
| New | +$321K | ﹤0.01% | 1501 |
|